通过N4-乙西丁介导的CD2BP2-DT驱动YBX1阶段分离以稳定CDK1并促进乳腺癌的进展
Hongyu Wang1, Bozhi Zhao1, Jiayu Zhang1
1Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
一种新的长非编码RNA (lncRNA),CD2BP2-DT,驱动乳腺癌细胞的增殖. 这种lncRNA增强了CDK1mRNA的稳定性,提供了作为生物标志物和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 与乳腺癌的发展有关.
- 许多lncRNAs在乳腺癌中的确切作用和机制尚未完全阐明.
研究的目的:
- 识别和描述涉及乳腺癌进展的新型lncRNAs.
- 研究CD2BP2-DT在乳腺癌中的功能作用和分子机制.
主要方法:
- 生物信息学分析以识别差异表达的 lncRNAs.
- 在体内和体外实验中评估乳腺癌细胞中的CD2BP2-DT功能.
- RNA免疫沉和西部斑点测试,以探索分子机制.
主要成果:
- CD2BP2-DT在乳腺癌中过度表达,并与预后不佳有关.
- CD2BP2-DT促进乳腺癌细胞的增殖.
- 通过NAT10介导的ac4C修饰增强了CD2BP2-DT的稳定性和表达.
- CD2BP2-DT通过YBX1相分离稳定了CDK1mRNA,从而推动了增殖.
结论:
- 在乳腺癌中,lncRNA CD2BP2-DT 作为关键瘤基因起作用.
- CD2BP2-DT通过YBX1/CDK1通路促进增殖.
- CD2BP2-DT代表了乳腺癌的潜在治疗标和生物标志物.
更多相关视频
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
